[Updated 21 January 2022]

Extension of Booster Vaccination Programme to Persons Aged 12 to 17 Years

MOH and the Expert Committee on COVID-19 Vaccination (EC19V) previously recommended that all persons aged 18 years and above should receive a booster dose of an mRNA vaccine offered under the National Vaccination Programme 5 months after completing their primary vaccination series. 

This recommendation is now extended to individuals aged 12 to 17 years. From early February 2022, individuals in this age group will be progressively invited to receive their booster dose, starting with those aged 16 and 17 years, followed by those aged 12 to 15 years. 

Those aged 12 to 17 years will require the consent of their parent/guardian to book an appointment. Parents/guardians of these individuals will receive an SMS with a personalised booking link to the mobile number they registered with for  the primary series, to provide consent and book their child/ward’s booster vaccination appointment.

Those in this age group can be boosted in any vaccination centre offering the Pfizer BioNTech/ Comirnaty vaccine and should bring along their Student Identification, or if not available, other forms of identification (e.g. Birth Certificate/Passport/SingPass) for verification purposes.

Parents/guardians of children/wards aged 13 and above are not required to  accompany them on the day of vaccination. However, children/wards aged12 and students of Special Education (SPED) schools will need to be accompanied by a parent/ guardian, as per the arrangements for the primary series vaccination.

Those aged 12 to 17 years who are medically ineligible for the Pfizer BioNTech/ Comirnaty vaccine will be offered a Sinovac-CoronaVac booster dose under a dedicated public health programme. This programme will also be extended to  children aged 5 to 11 years who are medically ineligible for the Pfizer-BioNTech/ Comirnaty vaccine for their primary vaccination series. Participants in the public health programme will be closely monitored by trained medical personnel.

Booster Dose Required to Maintain Fully Vaccinated Status 

From 14 February 2022, persons aged 18 years and above will be considered fully vaccinated only for 270 days after the last dose of their primary series of COVID-19 vaccines. Thereafter, to retain their fully vaccinated status, they need to receive a booster dose.

For example, if an individual completed his primary vaccination series on 1 June 2021, he would be eligible for a booster vaccination 5 months later, i.e. from 1 November 2021 onwards, and would have to receive his booster by 26 February 2022 to continue to be considered as fully vaccinated.

These requirements will apply to those aged 12 to 17 years from 14 March 2022 onwards.

Persons who have recovered from COVID-19 and have completed their primary  series vaccination1 do not require an additional booster dose at this point in time. They will continue to be considered fully vaccinated after 14 February 2022. However, it is safe for such persons to receive a booster dose from five months after their last dose and vaccination centres will not turn away such individuals. 

Persons aged 12 years and above who have been offered the booster dose should not delay receiving the booster dose beyond nine months after the last dose of their primary vaccination series.

Booster Recommendation for those vaccinated with Sinovac-CoronaVac and Sinopharm Vaccines

Persons who had received two or more doses of the Sinovac-CoronaVac or Sinopharm vaccines as part of a three-dose primary vaccination series are strongly recommended to receive one dose of an mRNA vaccine as a booster.

Additionally, the Sinovac-CoronaVac vaccine should only be  used as a booster by persons medically contraindicated to receive the mRNA vaccines. 

  1. Persons who had received an mRNA vaccine as the third dose of their  3-dose primary series should receive their booster around five months  thereafter. 

  2. Persons who received the Sinovac-CoronaVac or Sinopharm vaccine for all three doses should receive their booster at three months thereafter, due to lower antibody levels generated by the third vaccine dose. 

Booster Recommendation for the Immunocompromised

Those who are immunocompromised and have received a three-dose enhanced primary series are recommended to receive a booster dose of a Pandemic Special Access Route (PSAR) mRNA vaccine (i.e. a fourth dose of the vaccine). These persons can receive the booster dose from five months after completing the three-dose primary series. 

Registering for a Booster Dose

Eligible individuals will be invited to make an appointment for their booster dose. An SMS with a personalised booking link will be sent to their registered mobile number to book an appointment at www.vaccine.gov.sg. They may receive their booster dose at any vaccination centre or participating Public Health Preparedness Clinic.

Those who are eligible based on the criteria to-date, but have not received their SMS invitations, are also invited to walk in to any Pfizer-BioNTech/Comirnaty or Moderna Vaccination Centre to receive their booster vaccination without a need to book an appointment.

Those aged 60 years and above and are eligible for booster vaccination may walk into any of the participating Public Health Preparedness Clinics or polyclinics and Vaccination Centres to receive a booster dose without an appointment. 

1Persons who have recovered from COVID-19 and have completed their primary series vaccination  include those who were fully vaccinated when they were infected with COVID-19, and those who  received a valid dose of an mRNA vaccine (or two valid doses of Sinovac) after they were infected with  COVID-19.

Gov.sg is on Telegram! Click here to follow us.

Topics
COVID-19

DNR - Component System